CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes
Author(s) -
Partha Mukhopadhyay,
Mohanraj Rajesh,
Sándor Bátkai,
Vivek Patel,
Yoshihiro Kashiwaya,
Lucas Liaudet,
Oleg V. Evgenov,
Ken Mackie,
György Haskó,
Pál Pacher
Publication year - 2009
Publication title -
cardiovascular research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.774
H-Index - 219
eISSN - 1755-3245
pISSN - 0008-6363
DOI - 10.1093/cvr/cvp369
Subject(s) - cannabinoid receptor , oxidative stress , cardiomyopathy , doxorubicin , receptor , cannabinoid , medicine , programmed cell death , pharmacology , cancer research , heart failure , biology , apoptosis , chemotherapy , biochemistry , agonist
Here we investigated the mechanisms by which cardiovascular CB1 cannabinoid receptors may modulate the cardiac dysfunction, oxidative stress, and interrelated cell death pathways associated with acute/chronic cardiomyopathy induced by the widely used anti-tumour compound doxorubicin (DOX).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom